Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lensar Inc (NQ: LNSR )

4.630 +0.000 (+0.00%)
Streaming Delayed Price Updated: 9:47 AM EDT, Sep 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 400
Open 4.630
Bid (Size) 4.500 (11)
Ask (Size) 4.640 (1)
Prev. Close 4.630
Today's Range 4.630 - 4.630
52wk Range 1.800 - 5.600
Shares Outstanding 11,102,611
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LENSAR to Participate in Two Upcoming Investor Conferences
From LENSAR, Inc.
Via Business Wire
LNSR Stock Earnings: LENSAR Misses EPS, Beats Revenue for Q2 2024
LNSR stock results show that LENSAR missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
+14.61%
+14.61%
1 Month
-0.85%
-0.85%
3 Month
+7.68%
+7.68%
6 Month
+7.68%
+7.68%
1 Year
+33.82%
+33.82%

More News

Read More
LENSAR Reports Second Quarter 2024 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR Announces Certification for the ALLY® Adaptive Cataract Treatment System in the European Union
From LENSAR, Inc.
Via Business Wire
Earnings Preview: LENSAR
Via Benzinga
LENSAR's Earnings Outlook
Via Benzinga
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
From LENSAR, Inc.
Via Business Wire
3 Under-$10 Stocks With the Potential to Make You a Millionaire
Via InvestorPlace
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
From LENSAR, Inc.
Via Business Wire
LNSR Stock Earnings: LENSAR Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
LENSAR Reports First Quarter 2024 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
Earnings Scheduled For March 4, 2024
Via Benzinga
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Fourth Quarter and Full Year 2023 Financial Results on Monday, March 4, 2024
From LENSAR, Inc.
Via Business Wire
LENSAR Reports Third Quarter 2023 Results and Provides Business Update
From LENSAR, Inc.
Via Business Wire
LENSAR to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
From LENSAR, Inc.
Via Business Wire
Why NanoVibronix Shares Are Trading Higher By 49%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.